Literature DB >> 29214565

Intellectual Disability & Rare Disorders: A Diagnostic Challenge.

Malin Kvarnung1,2, Ann Nordgren3,4.   

Abstract

Rare disorders constitute a large and heterogeneous group of diagnoses of which many cause chronic disabilities with significant impact on the lives of affected individuals and their families as well as on the health-care system. Each individual disorder is rare, but when considered as a group, rare disorders are common with a total prevalence of approximately 6-8%. The clinical presentation of these disorders includes a broad diversity of symptoms and signs, often involving the nervous system and resulting in symptoms such as intellectual disability, neuropsychiatric disorders, epilepsy and motor dysfunction. The methods for establishing an etiological diagnosis in patients with rare disorders have improved dramatically during recent years. With the introduction of genomic screening methods, it has been shown that the cause is genetic in the majority of the patients and many will receive an etiological diagnosis in a clinical setting. However, there are a lot of challenges in diagnosing these disorders and despite recent years' advances, a large number of patients with rare disorders still go without an etiological diagnosis. In this chapter we will review the etiology of rare disorders with focus on intellectual disability and what has been learned from massive parallel sequencing studies in deciphering the genetic basis. Furthermore, we will discuss challenges in the etiological diagnostics of these disorders including issues that regard interpretation of the numerous genetic variants detected by genomic screening methods and challenges in the translation of massive parallel sequencing technologies into clinical practice.

Entities:  

Keywords:  Clinical diagnostics; Intellectual disability; Massive parallel sequencing; Neurodevelopmental disorders; Rare disorders; Whole exome sequencing; Whole genome sequencing

Mesh:

Year:  2017        PMID: 29214565     DOI: 10.1007/978-3-319-67144-4_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling.

Authors:  Nithya Selvan; Stephan George; Fatema J Serajee; Marie Shaw; Lynne Hobson; Vera Kalscheuer; Nripesh Prasad; Shawn E Levy; Juliet Taylor; Salim Aftimos; Charles E Schwartz; Ahm M Huq; Jozef Gecz; Lance Wells
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

2.  A missense mutation in the catalytic domain of O-GlcNAc transferase links perturbations in protein O-GlcNAcylation to X-linked intellectual disability.

Authors:  Veronica M Pravata; Mehmet Gundogdu; Sergio G Bartual; Andrew T Ferenbach; Marios Stavridis; Katrin Õunap; Sander Pajusalu; Riina Žordania; Monica H Wojcik; Daan M F van Aalten
Journal:  FEBS Lett       Date:  2019-11-07       Impact factor: 3.864

Review 3.  Rare Pathogenic Copy Number Variation in the 16p11.2 (BP4-BP5) Region Associated with Neurodevelopmental and Neuropsychiatric Disorders: A Review of the Literature.

Authors:  Natália Oliva-Teles; Maria Chiara de Stefano; Louise Gallagher; Severin Rakic; Paula Jorge; Goran Cuturilo; Silvana Markovska-Simoska; Isabella Borg; Jeanne Wolstencroft; Zeynep Tümer; Adrian J Harwood; Yllka Kodra; David Skuse
Journal:  Int J Environ Res Public Health       Date:  2020-12-10       Impact factor: 4.614

4.  De Novo 1q21.3q22 Duplication Revaluation in a "Cold" Complex Neuropsychiatric Case with Syndromic Intellectual Disability.

Authors:  Roberta Milone; Roberta Scalise; Rosa Pasquariello; Stefano Berloffa; Ivana Ricca; Roberta Battini
Journal:  Genes (Basel)       Date:  2021-03-31       Impact factor: 4.096

5.  Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders.

Authors:  Michael A Levy; Haley McConkey; Jennifer Kerkhof; Mouna Barat-Houari; Sara Bargiacchi; Elisa Biamino; María Palomares Bralo; Gerarda Cappuccio; Andrea Ciolfi; Angus Clarke; Barbara R DuPont; Mariet W Elting; Laurence Faivre; Timothy Fee; Robin S Fletcher; Florian Cherik; Aidin Foroutan; Michael J Friez; Cristina Gervasini; Sadegheh Haghshenas; Benjamin A Hilton; Zandra Jenkins; Simranpreet Kaur; Suzanne Lewis; Raymond J Louie; Silvia Maitz; Donatella Milani; Angela T Morgan; Renske Oegema; Elsebet Østergaard; Nathalie Ruiz Pallares; Maria Piccione; Simone Pizzi; Astrid S Plomp; Cathryn Poulton; Jack Reilly; Raissa Relator; Rocio Rius; Stephen Robertson; Kathleen Rooney; Justine Rousseau; Gijs W E Santen; Fernando Santos-Simarro; Josephine Schijns; Gabriella Maria Squeo; Miya St John; Christel Thauvin-Robinet; Giovanna Traficante; Pleuntje J van der Sluijs; Samantha A Vergano; Niels Vos; Kellie K Walden; Dimitar Azmanov; Tugce Balci; Siddharth Banka; Jozef Gecz; Peter Henneman; Jennifer A Lee; Marcel M A M Mannens; Tony Roscioli; Victoria Siu; David J Amor; Gareth Baynam; Eric G Bend; Kym Boycott; Nicola Brunetti-Pierri; Philippe M Campeau; John Christodoulou; David Dyment; Natacha Esber; Jill A Fahrner; Mark D Fleming; David Genevieve; Kristin D Kerrnohan; Alisdair McNeill; Leonie A Menke; Giuseppe Merla; Paolo Prontera; Cheryl Rockman-Greenberg; Charles Schwartz; Steven A Skinner; Roger E Stevenson; Antonio Vitobello; Marco Tartaglia; Marielle Alders; Matthew L Tedder; Bekim Sadikovic
Journal:  HGG Adv       Date:  2021-12-03

Review 6.  The limits of clinical findings in similar phenotypes, from Carpenter to ATRX syndrome using a whole exome sequencing approach: a case review.

Authors:  Samantha S Sáenz; Benjamin Arias; Kazuyoshi Hosomichi; Vanessa I Romero
Journal:  Hum Genomics       Date:  2021-08-04       Impact factor: 4.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.